1 Chagas Disease Drug Market Overview 1.1 Chagas Disease Drug Product Scope 1.2 Chagas Disease Drug Segment by Type 1.2.1 Global Chagas Disease Drug Sales by Type (2016 & 2021 & 2027) 1.2.2 Cz-007 1.2.3 Cz-008 1.2.4 D-121 1.2.5 DNDI-0690 1.2.6 EPLBS-1246 1.2.7 EPLBS-967 1.2.8 Others 1.3 Chagas Disease Drug Segment by Application 1.3.1 Global Chagas Disease Drug Sales Comparison by Application (2016 & 2021 & 2027) 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Others 1.4 Chagas Disease Drug Market Estimates and Forecasts (2016-2027) 1.4.1 Global Chagas Disease Drug Market Size in Value Growth Rate (2016-2027) 1.4.2 Global Chagas Disease Drug Market Size in Volume Growth Rate (2016-2027) 1.4.3 Global Chagas Disease Drug Price Trends (2016-2027) 2 Chagas Disease Drug Estimates and Forecasts by Region 2.1 Global Chagas Disease Drug Market Size by Region: 2016 VS 2021 VS 2027 2.2 Global Chagas Disease Drug Retrospective Market Scenario by Region (2016-2021) 2.2.1 Global Chagas Disease Drug Sales Market Share by Region (2016-2021) 2.2.2 Global Chagas Disease Drug Revenue Market Share by Region (2016-2021) 2.3 Global Chagas Disease Drug Market Estimates and Forecasts by Region (2022-2027) 2.3.1 Global Chagas Disease Drug Sales Estimates and Forecasts by Region (2022-2027) 2.3.2 Global Chagas Disease Drug Revenue Forecast by Region (2022-2027) 2.4 Geographic Market Analysis: Market Facts & Figures 2.4.1 North America Chagas Disease Drug Estimates and Projections (2016-2027) 2.4.2 Europe Chagas Disease Drug Estimates and Projections (2016-2027) 2.4.3 China Chagas Disease Drug Estimates and Projections (2016-2027) 2.4.4 Japan Chagas Disease Drug Estimates and Projections (2016-2027) 2.4.5 Southeast Asia Chagas Disease Drug Estimates and Projections (2016-2027) 2.4.6 India Chagas Disease Drug Estimates and Projections (2016-2027) 3 Global Chagas Disease Drug Competition Landscape by Players 3.1 Global Top Chagas Disease Drug Players by Sales (2016-2021) 3.2 Global Top Chagas Disease Drug Players by Revenue (2016-2021) 3.3 Global Chagas Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Chagas Disease Drug as of 2020) 3.4 Global Chagas Disease Drug Average Price by Company (2016-2021) 3.5 Manufacturers Chagas Disease Drug Manufacturing Sites, Area Served, Product Type 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Global Chagas Disease Drug Market Size by Type 4.1 Global Chagas Disease Drug Historic Market Review by Type (2016-2021) 4.1.1 Global Chagas Disease Drug Sales Market Share by Type (2016-2021) 4.1.2 Global Chagas Disease Drug Revenue Market Share by Type (2016-2021) 4.1.3 Global Chagas Disease Drug Price by Type (2016-2021) 4.2 Global Chagas Disease Drug Market Estimates and Forecasts by Type (2022-2027) 4.2.1 Global Chagas Disease Drug Sales Forecast by Type (2022-2027) 4.2.2 Global Chagas Disease Drug Revenue Forecast by Type (2022-2027) 4.2.3 Global Chagas Disease Drug Price Forecast by Type (2022-2027) 5 Global Chagas Disease Drug Market Size by Application 5.1 Global Chagas Disease Drug Historic Market Review by Application (2016-2021) 5.1.1 Global Chagas Disease Drug Sales Market Share by Application (2016-2021) 5.1.2 Global Chagas Disease Drug Revenue Market Share by Application (2016-2021) 5.1.3 Global Chagas Disease Drug Price by Application (2016-2021) 5.2 Global Chagas Disease Drug Market Estimates and Forecasts by Application (2022-2027) 5.2.1 Global Chagas Disease Drug Sales Forecast by Application (2022-2027) 5.2.2 Global Chagas Disease Drug Revenue Forecast by Application (2022-2027) 5.2.3 Global Chagas Disease Drug Price Forecast by Application (2022-2027) 6 North America Chagas Disease Drug Market Facts & Figures 6.1 North America Chagas Disease Drug Sales by Company 6.1.1 North America Chagas Disease Drug Sales by Company (2016-2021) 6.1.2 North America Chagas Disease Drug Revenue by Company (2016-2021) 6.2 North America Chagas Disease Drug Sales Breakdown by Type 6.2.1 North America Chagas Disease Drug Sales Breakdown by Type (2016-2021) 6.2.2 North America Chagas Disease Drug Sales Breakdown by Type (2022-2027) 6.3 North America Chagas Disease Drug Sales Breakdown by Application 6.3.1 North America Chagas Disease Drug Sales Breakdown by Application (2016-2021) 6.3.2 North America Chagas Disease Drug Sales Breakdown by Application (2022-2027) 7 Europe Chagas Disease Drug Market Facts & Figures 7.1 Europe Chagas Disease Drug Sales by Company 7.1.1 Europe Chagas Disease Drug Sales by Company (2016-2021) 7.1.2 Europe Chagas Disease Drug Revenue by Company (2016-2021) 7.2 Europe Chagas Disease Drug Sales Breakdown by Type 7.2.1 Europe Chagas Disease Drug Sales Breakdown by Type (2016-2021) 7.2.2 Europe Chagas Disease Drug Sales Breakdown by Type (2022-2027) 7.3 Europe Chagas Disease Drug Sales Breakdown by Application 7.3.1 Europe 133 Sales Breakdown by Application (2016-2021) 7.3.2 Europe 133 Sales Breakdown by Application (2022-2027) 8 China Chagas Disease Drug Market Facts & Figures 8.1 China Chagas Disease Drug Sales by Company 8.1.1 China Chagas Disease Drug Sales by Company (2016-2021) 8.1.2 China Chagas Disease Drug Revenue by Company (2016-2021) 8.2 China Chagas Disease Drug Sales Breakdown by Type 8.2.1 China Chagas Disease Drug Sales Breakdown by Type (2016-2021) 8.2.2 China Chagas Disease Drug Sales Breakdown by Type (2022-2027) 8.3 China Chagas Disease Drug Sales Breakdown by Application 8.3.1 China 153 Sales Breakdown by Application (2016-2021) 8.3.2 China 153 Sales Breakdown by Application (2022-2027) 9 Japan Chagas Disease Drug Market Facts & Figures 9.1 Japan Chagas Disease Drug Sales by Company 9.1.1 Japan Chagas Disease Drug Sales by Company (2016-2021) 9.1.2 Japan Chagas Disease Drug Revenue by Company (2016-2021) 9.2 Japan Chagas Disease Drug Sales Breakdown by Type 9.2.1 Japan Chagas Disease Drug Sales Breakdown by Type (2016-2021) 9.2.2 Japan Chagas Disease Drug Sales Breakdown by Type (2022-2027) 9.3 Japan Chagas Disease Drug Sales Breakdown by Application 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021) 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027) 10 Southeast Asia Chagas Disease Drug Market Facts & Figures 10.1 Southeast Asia Chagas Disease Drug Sales by Company 10.1.1 Southeast Asia Chagas Disease Drug Sales by Company (2016-2021) 10.1.2 Southeast Asia Chagas Disease Drug Revenue by Company (2016-2021) 10.2 Southeast Asia Chagas Disease Drug Sales Breakdown by Type 10.2.1 Southeast Asia Chagas Disease Drug Sales Breakdown by Type (2016-2021) 10.2.2 Southeast Asia Chagas Disease Drug Sales Breakdown by Type (2022-2027) 10.3 Southeast Asia Chagas Disease Drug Sales Breakdown by Application 10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021) 10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027) 11 India Chagas Disease Drug Market Facts & Figures 11.1 India Chagas Disease Drug Sales by Company 11.1.1 India Chagas Disease Drug Sales by Company (2016-2021) 11.1.2 India Chagas Disease Drug Revenue by Company (2016-2021) 11.2 India Chagas Disease Drug Sales Breakdown by Type 11.2.1 India Chagas Disease Drug Sales Breakdown by Type (2016-2021) 11.2.2 India Chagas Disease Drug Sales Breakdown by Type (2022-2027) 11.3 India Chagas Disease Drug Sales Breakdown by Application 11.3.1 India Chagas Disease Drug Sales Breakdown by Application (2016-2021) 11.3.2 India Chagas Disease Drug Sales Breakdown by Application (2022-2027) 12 Company Profiles and Key Figures in Chagas Disease Drug Business 12.1 AstraZeneca Plc 12.1.1 AstraZeneca Plc Corporation Information 12.1.2 AstraZeneca Plc Business Overview 12.1.3 AstraZeneca Plc Chagas Disease Drug Sales, Revenue and Gross Margin (2016-2021) 12.1.4 AstraZeneca Plc Chagas Disease Drug Products Offered 12.1.5 AstraZeneca Plc Recent Development 12.2 Bayer AG 12.2.1 Bayer AG Corporation Information 12.2.2 Bayer AG Business Overview 12.2.3 Bayer AG Chagas Disease Drug Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Bayer AG Chagas Disease Drug Products Offered 12.2.5 Bayer AG Recent Development 12.3 Daiichi Sankyo Co Ltd 12.3.1 Daiichi Sankyo Co Ltd Corporation Information 12.3.2 Daiichi Sankyo Co Ltd Business Overview 12.3.3 Daiichi Sankyo Co Ltd Chagas Disease Drug Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Daiichi Sankyo Co Ltd Chagas Disease Drug Products Offered 12.3.5 Daiichi Sankyo Co Ltd Recent Development 12.4 Eisai Co Ltd 12.4.1 Eisai Co Ltd Corporation Information 12.4.2 Eisai Co Ltd Business Overview 12.4.3 Eisai Co Ltd Chagas Disease Drug Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Eisai Co Ltd Chagas Disease Drug Products Offered 12.4.5 Eisai Co Ltd Recent Development 12.5 GlaxoSmithKline Plc 12.5.1 GlaxoSmithKline Plc Corporation Information 12.5.2 GlaxoSmithKline Plc Business Overview 12.5.3 GlaxoSmithKline Plc Chagas Disease Drug Sales, Revenue and Gross Margin (2016-2021) 12.5.4 GlaxoSmithKline Plc Chagas Disease Drug Products Offered 12.5.5 GlaxoSmithKline Plc Recent Development 12.6 Grupo Praxis Pharmaceutical SA 12.6.1 Grupo Praxis Pharmaceutical SA Corporation Information 12.6.2 Grupo Praxis Pharmaceutical SA Business Overview 12.6.3 Grupo Praxis Pharmaceutical SA Chagas Disease Drug Sales, Revenue and Gross Margin (2016-2021) 12.6.4 Grupo Praxis Pharmaceutical SA Chagas Disease Drug Products Offered 12.6.5 Grupo Praxis Pharmaceutical SA Recent Development 12.7 Humanigen Inc 12.7.1 Humanigen Inc Corporation Information 12.7.2 Humanigen Inc Business Overview 12.7.3 Humanigen Inc Chagas Disease Drug Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Humanigen Inc Chagas Disease Drug Products Offered 12.7.5 Humanigen Inc Recent Development 12.8 Kancera AB 12.8.1 Kancera AB Corporation Information 12.8.2 Kancera AB Business Overview 12.8.3 Kancera AB Chagas Disease Drug Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Kancera AB Chagas Disease Drug Products Offered 12.8.5 Kancera AB Recent Development 12.9 Merck & Co Inc 12.9.1 Merck & Co Inc Corporation Information 12.9.2 Merck & Co Inc Business Overview 12.9.3 Merck & Co Inc Chagas Disease Drug Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Merck & Co Inc Chagas Disease Drug Products Offered 12.9.5 Merck & Co Inc Recent Development 12.10 Novartis AG 12.10.1 Novartis AG Corporation Information 12.10.2 Novartis AG Business Overview 12.10.3 Novartis AG Chagas Disease Drug Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Novartis AG Chagas Disease Drug Products Offered 12.10.5 Novartis AG Recent Development 12.11 Oblita Therapeutics BVBA 12.11.1 Oblita Therapeutics BVBA Corporation Information 12.11.2 Oblita Therapeutics BVBA Business Overview 12.11.3 Oblita Therapeutics BVBA Chagas Disease Drug Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Oblita Therapeutics BVBA Chagas Disease Drug Products Offered 12.11.5 Oblita Therapeutics BVBA Recent Development 12.12 Sanofi 12.12.1 Sanofi Corporation Information 12.12.2 Sanofi Business Overview 12.12.3 Sanofi Chagas Disease Drug Sales, Revenue and Gross Margin (2016-2021) 12.12.4 Sanofi Chagas Disease Drug Products Offered 12.12.5 Sanofi Recent Development 13 Chagas Disease Drug Manufacturing Cost Analysis 13.1 Chagas Disease Drug Key Raw Materials Analysis 13.1.1 Key Raw Materials 13.1.2 Key Raw Materials Price Trend 13.1.3 Key Suppliers of Raw Materials 13.2 Proportion of Manufacturing Cost Structure 13.3 Manufacturing Process Analysis of Chagas Disease Drug 13.4 Chagas Disease Drug Industrial Chain Analysis 14 Marketing Channel, Distributors and Customers 14.1 Marketing Channel 14.2 Chagas Disease Drug Distributors List 14.3 Chagas Disease Drug Customers 15 Market Dynamics 15.1 Chagas Disease Drug Market Trends 15.2 Chagas Disease Drug Drivers 15.3 Chagas Disease Drug Market Challenges 15.4 Chagas Disease Drug Market Restraints 16 Research Findings and Conclusion 17 Appendix 17.1 Research Methodology 17.1.1 Methodology/Research Approach 17.1.2 Data Source 17.2 Author List 17.3 Disclaimer

List of Tables Table 1. Global Chagas Disease Drug Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027) Table 2. Global Chagas Disease Drug Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027) Table 3. Global Chagas Disease Drug Market Size (US$ Million) by Region: 2016 VS 2021 &2027 Table 4. Global Chagas Disease Drug Sales (K Pcs) by Region (2016-2021) Table 5. Global Chagas Disease Drug Sales Market Share by Region (2016-2021) Table 6. Global Chagas Disease Drug Revenue (US$ Million) Market Share by Region (2016-2021)) Table 7. Global Chagas Disease Drug Revenue Share by Region (2016-2021) Table 8. Global Chagas Disease Drug Sales (K Pcs) Forecast by Region (2022-2027) Table 9. Global Chagas Disease Drug Sales Market Share Forecast by Region (2022-2027) Table 10. Global Chagas Disease Drug Revenue (US$ Million) Forecast by Region (2022-2027) Table 11. Global Chagas Disease Drug Revenue Share Forecast by Region (2022-2027) Table 12. Global Chagas Disease Drug Sales (K Pcs) of Key Companies (2016-2021) Table 13. Global Chagas Disease Drug Sales Share by Company (2016-2021) Table 14. Global Chagas Disease Drug Revenue (US$ Million) by Company (2016-2021) Table 15. Global Chagas Disease Drug Revenue Share by Company (2016-2021) Table 16. Global Chagas Disease Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chagas Disease Drug as of 2020) Table 17. Global Chagas Disease Drug Average Price (USD/Pcs) of Key Company (2016-2021) Table 18. Manufacturers Chagas Disease Drug Manufacturing Sites and Area Served Table 19. Manufacturers Chagas Disease Drug Product Type Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans Table 21. Global Chagas Disease Drug Sales (K Pcs) by Type (2016-2021) Table 22. Global Chagas Disease Drug Sales Share by Type (2016-2021) Table 23. Global Chagas Disease Drug Revenue (US$ Million) Market Share by Type (2016-2021) Table 24. Global Chagas Disease Drug Price (USD/Pcs) by Type (2016-2021) Table 25. Global Chagas Disease Drug Sales Share by Type (2022-2027) Table 26. Global Chagas Disease Drug Revenue (US$ Million) Market Share by Type (2022-2027) Table 27. Global Chagas Disease Drug Revenue Share by Type (2022-2027) Table 28. Global Chagas Disease Drug Price (USD/Pcs) by Type (2022-2027) Table 29. Global Chagas Disease Drug Sales (K Pcs) by Application (2016-2021) Table 30. Global Chagas Disease Drug Sales Share by Application (2016-2021) Table 31. Global Chagas Disease Drug Revenue (US$ Million) Market Share by Application (2016-2021) Table 32. Global Chagas Disease Drug Price (USD/Pcs) by Application (2016-2021) Table 33. Global Chagas Disease Drug Sales (K Pcs) by Application (2022-2027) Table 34. Global Chagas Disease Drug Sales Share by Application (2022-2027) Table 35. Global Chagas Disease Drug Revenue (US$ Million) Market Share by Application (2022-2027) Table 36. Global Chagas Disease Drug Revenue Share by Application (2022-2027) Table 37. Global Chagas Disease Drug Price (USD/Pcs) by Application (2022-2027) Table 38. North America Chagas Disease Drug Sales (K Pcs) by Company (2016-2021) Table 39. North America Chagas Disease Drug Sales Market Share by Company (2016-2021) Table 40. North America Chagas Disease Drug Revenue by Company (2016-2021) & (US$ Million) Table 41. North America Chagas Disease Drug Revenue Market Share by Company (2016-2021) Table 42. North America Chagas Disease Drug Sales by Type (2016-2021) & (K Pcs) Table 43. North America Chagas Disease Drug Sales Market Share by Type (2016-2021) Table 44. North America Chagas Disease Drug Sales by Type (2022-2027) & (K Pcs) Table 45. North America Chagas Disease Drug Sales Market Share by Type (2022-2027) Table 46. North America Chagas Disease Drug Sales by Application (2016-2021) & (K Pcs) Table 47. North America Chagas Disease Drug Sales Market Share by Application (2016-2021) Table 48. North America Chagas Disease Drug Sales by Application (2022-2027) & (K Pcs) Table 49. North America Chagas Disease Drug Sales Market Share by Application (2022-2027) Table 50. Europe Chagas Disease Drug Sales (K Pcs) by Company (2016-2021) Table 51. Europe Chagas Disease Drug Sales Market Share by Company (2016-2021) Table 52. Europe Chagas Disease Drug Revenue by Company (2016-2021) & (US$ Million) Table 53. Europe Chagas Disease Drug Revenue Market Share by Company (2016-2021) Table 54. Europe Chagas Disease Drug Sales by Type (2016-2021) & (K Pcs) Table 55. Europe Chagas Disease Drug Sales Market Share by Type (2016-2021) Table 56. Europe Chagas Disease Drug Sales by Type (2022-2027) & (K Pcs) Table 57. Europe Chagas Disease Drug Sales Market Share by Type (2022-2027) Table 58. Europe Chagas Disease Drug Sales by Application (2016-2021) & (K Pcs) Table 59. Europe Chagas Disease Drug Sales Market Share by Application (2016-2021) Table 60. Europe Chagas Disease Drug Sales by Application (2022-2027) & (K Pcs) Table 61. Europe Chagas Disease Drug Sales Market Share by Application (2022-2027) Table 62. China Chagas Disease Drug Sales (K Pcs) by Company (2016-2021) Table 63. China Chagas Disease Drug Sales Market Share by Company (2016-2021) Table 64. China Chagas Disease Drug Revenue by Company (2016-2021) & (US$ Million) Table 65. China Chagas Disease Drug Revenue Market Share by Company (2016-2021) Table 66. China Chagas Disease Drug Sales by Type (2016-2021) & (K Pcs) Table 67. China Chagas Disease Drug Sales Market Share by Type (2016-2021) Table 68. China Chagas Disease Drug Sales by Type (2022-2027) & (K Pcs) Table 69. China Chagas Disease Drug Sales Market Share by Type (2022-2027) Table 70. China Chagas Disease Drug Sales by Application (2016-2021) & (K Pcs) Table 71. China Chagas Disease Drug Sales Market Share by Application (2016-2021) Table 72. China Chagas Disease Drug Sales by Application (2022-2027) & (K Pcs) Table 73. China Chagas Disease Drug Sales Market Share by Application (2022-2027) Table 74. Japan Chagas Disease Drug Sales (K Pcs) by Company (2016-2021) Table 75. Japan Chagas Disease Drug Sales Market Share by Company (2016-2021) Table 76. Japan Chagas Disease Drug Revenue by Company (2016-2021) & (US$ Million) Table 77. Japan Chagas Disease Drug Revenue Market Share by Company (2016-2021) Table 78. Japan Chagas Disease Drug Sales by Type (2016-2021) & (K Pcs) Table 79. Japan Chagas Disease Drug Sales Market Share by Type (2016-2021) Table 80. Japan Chagas Disease Drug Sales by Type (2022-2027) & (K Pcs) Table 81. Japan Chagas Disease Drug Sales Market Share by Type (2022-2027) Table 82. Japan Chagas Disease Drug Sales by Application (2016-2021) & (K Pcs) Table 83. Japan Chagas Disease Drug Sales Market Share by Application (2016-2021) Table 84. Japan Chagas Disease Drug Sales by Application (2022-2027) & (K Pcs) Table 85. Japan Chagas Disease Drug Sales Market Share by Application (2022-2027) Table 86. Southeast Asia Chagas Disease Drug Sales (K Pcs) by Company (2016-2021) Table 87. Southeast Asia Chagas Disease Drug Sales Market Share by Company (2016-2021) Table 88. Southeast Asia Chagas Disease Drug Revenue by Company (2016-2021) & (US$ Million) Table 89. Southeast Asia Chagas Disease Drug Revenue Market Share by Company (2016-2021) Table 90. Southeast Asia Chagas Disease Drug Sales by Type (2016-2021) & (K Pcs) Table 91. Southeast Asia Chagas Disease Drug Sales Market Share by Type (2016-2021) Table 92. Southeast Asia Chagas Disease Drug Sales by Type (2022-2027) & (K Pcs) Table 93. Southeast Asia Chagas Disease Drug Sales Market Share by Type (2022-2027) Table 94. Southeast Asia Chagas Disease Drug Sales by Application (2016-2021) & (K Pcs) Table 95. Southeast Asia Chagas Disease Drug Sales Market Share by Application (2016-2021) Table 96. Southeast Asia Chagas Disease Drug Sales by Application (2022-2027) & (K Pcs) Table 97. Southeast Asia Chagas Disease Drug Sales Market Share by Application (2022-2027) Table 98. India Chagas Disease Drug Sales (K Pcs) by Company (2016-2021) Table 99. India Chagas Disease Drug Sales Market Share by Company (2016-2021) Table 100. India Chagas Disease Drug Revenue by Company (2016-2021) & (US$ Million) Table 101. India Chagas Disease Drug Revenue Market Share by Company (2016-2021) Table 102. India Chagas Disease Drug Sales by Type (2016-2021) & (K Pcs) Table 103. India Chagas Disease Drug Sales Market Share by Type (2016-2021) Table 104. India Chagas Disease Drug Sales by Type (2022-2027) & (K Pcs) Table 105. India Chagas Disease Drug Sales Market Share by Type (2022-2027) Table 106. India Chagas Disease Drug Sales by Application (2016-2021) & (K Pcs) Table 107. India Chagas Disease Drug Sales Market Share by Application (2016-2021) Table 108. India Chagas Disease Drug Sales by Application (2022-2027) & (K Pcs) Table 109. India Chagas Disease Drug Sales Market Share by Application (2022-2027) Table 110. AstraZeneca Plc Corporation Information Table 111. AstraZeneca Plc Description and Business Overview Table 112. AstraZeneca Plc Chagas Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 113. AstraZeneca Plc Chagas Disease Drug Product Table 114. AstraZeneca Plc Recent Development Table 115. Bayer AG Corporation Information Table 116. Bayer AG Description and Business Overview Table 117. Bayer AG Chagas Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 118. Bayer AG Chagas Disease Drug Product Table 119. Bayer AG Recent Development Table 120. Daiichi Sankyo Co Ltd Corporation Information Table 121. Daiichi Sankyo Co Ltd Description and Business Overview Table 122. Daiichi Sankyo Co Ltd Chagas Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 123. Daiichi Sankyo Co Ltd Chagas Disease Drug Product Table 124. Daiichi Sankyo Co Ltd Recent Development Table 125. Eisai Co Ltd Corporation Information Table 126. Eisai Co Ltd Description and Business Overview Table 127. Eisai Co Ltd Chagas Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 128. Eisai Co Ltd Chagas Disease Drug Product Table 129. Eisai Co Ltd Recent Development Table 130. GlaxoSmithKline Plc Corporation Information Table 131. GlaxoSmithKline Plc Description and Business Overview Table 132. GlaxoSmithKline Plc Chagas Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 133. GlaxoSmithKline Plc Chagas Disease Drug Product Table 134. GlaxoSmithKline Plc Recent Development Table 135. Grupo Praxis Pharmaceutical SA Corporation Information Table 136. Grupo Praxis Pharmaceutical SA Description and Business Overview Table 137. Grupo Praxis Pharmaceutical SA Chagas Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 138. Grupo Praxis Pharmaceutical SA Chagas Disease Drug Product Table 139. Grupo Praxis Pharmaceutical SA Recent Development Table 140. Humanigen Inc Corporation Information Table 141. Humanigen Inc Description and Business Overview Table 142. Humanigen Inc Chagas Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 143. Humanigen Inc Chagas Disease Drug Product Table 144. Humanigen Inc Recent Development Table 145. Kancera AB Corporation Information Table 146. Kancera AB Chagas Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 147. Kancera AB Description and Business Overview Table 148. Kancera AB Chagas Disease Drug Product Table 149. Kancera AB Recent Development Table 150. Merck & Co Inc Corporation Information Table 151. Merck & Co Inc Chagas Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 152. Merck & Co Inc Description and Business Overview Table 153. Merck & Co Inc Chagas Disease Drug Product Table 154. Merck & Co Inc Recent Development Table 155. Novartis AG Corporation Information Table 156. Novartis AG Description and Business Overview Table 157. Novartis AG Chagas Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 158. Novartis AG Chagas Disease Drug Product Table 159. Novartis AG Recent Development Table 160. Oblita Therapeutics BVBA Corporation Information Table 161. Oblita Therapeutics BVBA Description and Business Overview Table 162. Oblita Therapeutics BVBA Chagas Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 163. Oblita Therapeutics BVBA Chagas Disease Drug Product Table 164. Oblita Therapeutics BVBA Recent Development Table 165. Sanofi Corporation Information Table 166. Sanofi Description and Business Overview Table 167. Sanofi Chagas Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 168. Sanofi Chagas Disease Drug Product Table 169. Sanofi Recent Development Table 170. Production Base and Market Concentration Rate of Raw Material Table 171. Key Suppliers of Raw Materials Table 172. Chagas Disease Drug Distributors List Table 173. Chagas Disease Drug Customers List Table 174. Chagas Disease Drug Market Trends Table 175. Chagas Disease Drug Market Drivers Table 176. Chagas Disease Drug Market Challenges Table 177. Chagas Disease Drug Market Restraints Table 178. Research Programs/Design for This Report Table 179. Key Data Information from Secondary Sources Table 180. Key Data Information from Primary Sources List of Figures Figure 1. Chagas Disease Drug Product Picture Figure 2. Global Chagas Disease Drug Sales Market Share by Type in 2021 & 2027 Figure 3. Cz-007 Product Picture Figure 4. Cz-008 Product Picture Figure 5. D-121 Product Picture Figure 6. DNDI-0690 Product Picture Figure 7. EPLBS-1246 Product Picture Figure 8. EPLBS-967 Product Picture Figure 9. Others Product Picture Figure 10. Global Chagas Disease Drug Sales Market Share by Application in 2021 & 2027 Figure 11. Hospital Examples Figure 12. Clinic Examples Figure 13. Others Examples Figure 14. Global Chagas Disease Drug Sales, (US$ Million), 2016 VS 2021 VS 2027 Figure 15. Global Chagas Disease Drug Sales Growth Rate (2016-2027) & (US$ Million) Figure 16. Global Chagas Disease Drug Sales (K Pcs) Growth Rate (2016-2027) Figure 17. Global Chagas Disease Drug Price Trends Growth Rate (2016-2027) (USD/Pcs) Figure 18. Global Chagas Disease Drug Revenue Market Share by Region: 2016 VS 2021 Figure 19. Global Chagas Disease Drug Revenue Market Share by Region: 2021 VS 2027 Figure 20. North America Chagas Disease Drug Revenue (Million USD) Growth Rate (2016-2027) Figure 21. North America Chagas Disease Drug Sales (K Pcs) Growth Rate (2016-2027) Figure 22. Europe Chagas Disease Drug Revenue (Million USD) Growth Rate (2016-2027) Figure 23. Europe Chagas Disease Drug Sales (Million USD) Growth Rate (2016-2027) Figure 24. China Chagas Disease Drug Revenue (Million USD) Growth Rate (2016-2027) Figure 25. China Chagas Disease Drug Sales (Million USD) and Growth Rate (2016-2027) Figure 26. Japan Chagas Disease Drug Revenue (Million USD) Growth Rate (2016-2027) Figure 27. Japan Chagas Disease Drug Sales (Million USD) Growth Rate (2016-2027) Figure 28. Southeast Asia Chagas Disease Drug Revenue (Million USD) Growth Rate (2016-2027) Figure 29. Southeast Asia Chagas Disease Drug Sales (Million USD) Growth Rate (2016-2027) Figure 30. India Chagas Disease Drug Revenue (Million USD) Growth Rate (2016-2027) Figure 31. India Chagas Disease Drug Sales (Million USD) Growth Rate (2016-2027) Figure 32. Global 5 Largest Chagas Disease Drug Players Market Share by Revenue in Chagas Disease Drug: 2016 & 2020 Figure 33. Chagas Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 34. Global Chagas Disease Drug Revenue Share by Type (2016-2021) Figure 35. Global Chagas Disease Drug Revenue Growth Rate by Type in 2016 & 2020 Figure 36. Global Chagas Disease Drug Revenue Share by Application (2016-2021) Figure 37. Global Chagas Disease Drug Revenue Growth Rate by Application in 2016 & 2020 Figure 38. North America Chagas Disease Drug Sales Market Share by Type in 2020 Figure 39. North America Chagas Disease Drug Sales Market Share by Application in 2020 Figure 40. Europe Chagas Disease Drug Sales Market Share by Type in 2020 Figure 41. Europe Chagas Disease Drug Sales Market Share by Application in 2020 Figure 42. China Chagas Disease Drug Sales Market Share by Type in 2020 Figure 43. China Chagas Disease Drug Sales Market Share by Application in 2020 Figure 44. Japan Chagas Disease Drug Sales Market Share by Type in 2020 Figure 45. Japan Chagas Disease Drug Sales Market Share by Application in 2020 Figure 46. Southeast Asia Chagas Disease Drug Sales Market Share by Type in 2020 Figure 47. Southeast Asia Chagas Disease Drug Sales Market Share by Application in 2020 Figure 48. India Chagas Disease Drug Sales Market Share by Type in 2020 Figure 49. India Chagas Disease Drug Sales Market Share by Application in 2020 Figure 50. Key Raw Materials Price Trend Figure 51. Manufacturing Cost Structure of Chagas Disease Drug Figure 52. Manufacturing Process Analysis of Chagas Disease Drug Figure 53. Chagas Disease Drug Industrial Chain Analysis Figure 54. Channels of Distribution Figure 55. Distributors Profiles Figure 56. Bottom-up and Top-down Approaches for This Report Figure 57. Data Triangulation Figure 58. Key Executives Interviewed

AstraZeneca Plc Bayer AG Daiichi Sankyo Co Ltd Eisai Co Ltd GlaxoSmithKline Plc Grupo Praxis Pharmaceutical SA Humanigen Inc Kancera AB Merck & Co Inc Novartis AG Oblita Therapeutics BVBA Sanofi